Cargando…

Characterization of SARS‐CoV‐2 humoral immune response in a subject with unique sampling: A case report

BACKGROUND: The development of vaccine candidates for COVID‐19, and the administration of booster vaccines, has meant a significant reduction in COVID‐19 related deaths world‐wide and the easing of global restrictions. However, new variants of SARS‐CoV‐2 have emerged with less susceptibility to vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Melanie R., Idorn, Manja, Bennett, Anja, Søgaard, Max, Salanti, Ali, Ditlev, Sisse B., Barfod, Lea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266136/ https://www.ncbi.nlm.nih.gov/pubmed/37382252 http://dx.doi.org/10.1002/iid3.910

Ejemplares similares

SARS-CoV-2 RBD-Specific Antibodies Induced Early in the Pandemic by Natural Infection and Vaccination Display Cross-Variant Binding and Inhibition
por: Walker, Melanie R., et al.
Publicado: (2022)

Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 Variants per Genome Can Bind IgM via Its Fc Fragment Fcμ
por: Jeppesen, Anine, et al.
Publicado: (2015)

Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
por: Svenningsen, Esben B., et al.
Publicado: (2021)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Absence of Herpesvirus DNA in Aqueous Humor from Asymptomatic Subjects
por: von Hofsten, Joanna, et al.
Publicado: (2022)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA
por: Ditlev, Sisse B., et al.
Publicado: (2014)

LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination
por: Cheon, Heejin, et al.
Publicado: (2022)

Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation
por: KRAJEWSKI, Piotr K., et al.
Publicado: (2021)

Limitations in assessing nerve growth factor levels in aqueous humor samples from human eyes
por: Chalam, Kakarla V, et al.
Publicado: (2008)

Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
por: Idorn, Manja, et al.
Publicado: (2018)

Exercise and cancer: from “healthy” to “therapeutic”?
por: Idorn, Manja, et al.
Publicado: (2017)

Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses
por: Dhochak, Nitin, et al.
Publicado: (2022)

Suitability of individual and bulk milk samples to investigate the humoral immune response to lumpy skin disease vaccination by ELISA
por: Milovanović, Milovan, et al.
Publicado: (2020)

Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
por: Anastasi, Emanuela, et al.
Publicado: (2022)

Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA
por: Resende, Mafalda, et al.
Publicado: (2008)

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
por: Salanti, Ali, et al.
Publicado: (2010)

Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)

Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients
por: Cuffel, Alexis, et al.
Publicado: (2022)

Prevalence of anti-Toxoplasma gondii antibodies in serum and aqueous humor samples from cats with uveitis or systemic diseases in France
por: Meunier, Valérie, et al.
Publicado: (2006)

Evaluation of SARS-CoV-2 viral RNA in fecal samples
por: Mesoraca, Alvaro, et al.
Publicado: (2020)

Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
por: Vollenberg, Richard, et al.
Publicado: (2023)

Sars-CoV2 vaccine hesitancy in Italy: A survey on subjects with diabetes
por: Scoccimarro, Daniele, et al.
Publicado: (2021)

Development of SARS-CoV-2 variant protein microarray for profiling humoral immunity in vaccinated subjects
por: Ho, Tzong-Shiann, et al.
Publicado: (2022)

Pooling of SARS-CoV-2 samples to increase molecular testing throughput
por: Perchetti, Garrett A., et al.
Publicado: (2020)

A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
por: Thrane, Susan, et al.
Publicado: (2015)

Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples
por: Gupta, Akshita, et al.
Publicado: (2021)

Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel
por: Bar-Or, Itay, et al.
Publicado: (2021)

Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA
por: Pinto, Vera V., et al.
Publicado: (2011)

Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies
por: Khunrae, Pongsak, et al.
Publicado: (2010)

Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
por: Li, Jian, et al.
Publicado: (2021)

Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling
por: Alcoba-Florez, Julia, et al.
Publicado: (2021)

Viral infectivity in paediatric SARS-CoV-2 clinical samples does not vary by age
por: Schmidt, Madaline M., et al.
Publicado: (2023)

Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
por: Kato, Hideaki, et al.
Publicado: (2022)

The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
por: Dahlbäck, Madeleine, et al.
Publicado: (2011)

Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
por: Brisotto, Giulia, et al.
Publicado: (2023)

Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples
por: Alcoba-Florez, Julia, et al.
Publicado: (2020)

Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples()
por: Veillette, Maxime, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_urigaqmabj4leqggc5a2104bfu